speb/financial-data huggingface dataset:
Stock screener scorecard for TCI.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.884407023037253 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.148102029301321%
Earnings yield: 0.015911155245883785%
Return on net tangible assets: 4.85631926105934%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.6958092435448147%
Revenue growth: 0.8492748205721214%
Rule of 40 score: 0.8492748205721214
Market cap: 70511779840 (Large Cap ($10B-$200B))
P/E ratio: 0.16382445571958276
Debt to equity: 0.1199
Operating income: 11297159.813480288
Net income: 13194150.063586265
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TCI.NS (annual, report date 2026-03-31)
Altman Z-score: 7.016570617255169 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 8.311769169406775%
Earnings yield: 0.031882014639031675%
Return on net tangible assets: 6.822367933470376%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.405486439223005%
Free cash flow margin: 0.4949382563761848%
Revenue growth: -0.7606433246021815%
Rule of 40 score: -0.2657050682259967
Market cap: 70511779840 (Large Cap ($10B-$200B))
P/E ratio: 0.16382445571958276
Debt to equity: 0.1199
Free cash flow (dilution adjusted): 2576833.4039847394
Operating income: 22636710.470538363
Net income: 48736858.83849089
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for TWM.TO (quarterly, report date 2026-03-31)
Altman Z-score: 0.17473733290188526 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 4.377328366152209%
Earnings yield: 2.596945450697115%
Return on net tangible assets: -6.453674121405749%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.096115537848606%
Free cash flow margin: 0.4927385892116182%
Revenue growth: -0.4839490544249525%
Rule of 40 score: 0.00878953478666572
Market cap: 466094016 (Small Cap ($300M-$2B))
Debt to equity: 2.9288
Free cash flow (dilution adjusted): 1366906.474820144
Operating income: 23669064.74820144
Net income: -15683453.237410072
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for USFD (quarterly, report date 2026-03-31)
Altman Z-score: 2.358775492382714 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.907184705519581%
Earnings yield: 0.8397395383232941%
Return on net tangible assets: -6.193895870736086%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.165297245045916%
Free cash flow margin: 1.810613943808533%
Revenue growth: -1.9387755102040816%
Rule of 40 score: -0.12816156639554865
Market cap: 21398939648 (Large Cap ($10B-$200B))
P/E ratio: 31.04713804713804
Debt to equity: 1.2289
Free cash flow (dilution adjusted): 174000000
Operating income: 224000000
Net income: 116000000
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1605.T (annual, report date 2025-12-31)
Altman Z-score: 2.154037746139418 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 25.414556638307754%
Earnings yield: 0.11861516637666325%
Return on net tangible assets: 9.201440831894308%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.420732401474288%
Revenue growth: -10.902262721870486%
Rule of 40 score: -10.902262721870486
Market cap: 3584772596905.6294 (Mega Cap (>= $200B))
P/E ratio: 8.343704693033738
Debt to equity: 0.24781406290346436
Operating income: 6798427210.536411
Net income: 2746870404.7055817
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1YD.DE (annual, report date 2025-10-31)
Altman Z-score: 12.786756904548243 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 167.26537943421644%
Earnings yield: 1.5791543348957697%
Return on net tangible assets: -64.11791234471731%
Capitalized R&D asset: 18948190000
ROCI (R&D adjusted): 16.638081138901683%
Rosenberg metric: 1.1584317937701396
Free cash flow margin: 30.28159093399283%
Revenue growth: 23.874432853763526%
Rule of 40 score: 54.156023787756354
Market cap: 1756930110561.4185 (Mega Cap (>= $200B))
P/E ratio: 75.97207085364604
Debt to equity: 0.8012596565467697
Free cash flow (dilution adjusted): 19346000000
Operating income: 26075000000
Net income: 23126000000
Long score: 13 | Short score: 3
Recommendation: Long
Stock screener scorecard for 3543.T (annual, report date 2026-02-28)
Altman Z-score: 2.66319234629715 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 43.72071445140339%
Earnings yield: 0.03749707520397298%
Return on net tangible assets: 73.633988413041%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.028305701577032%
Revenue growth: 17.04344715723957%
Rule of 40 score: 17.04344715723957
Market cap: 133390404992.99998 (Large Cap ($10B-$200B))
P/E ratio: 20.57858762619562
Debt to equity: 0.8502213183395144
Operating income: 60464519.44052354
Net income: 41588605.15847555
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 3675.T (annual, report date 2025-06-30)
Altman Z-score: 4.381803725865363 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 32.931537982902675%
Earnings yield: 0.2402784587345304%
Return on net tangible assets: 30.491636747678086%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.92742385976972%
Free cash flow margin: 5.783821059295269%
Revenue growth: 22.705132591234108%
Rule of 40 score: 28.488953650529375
Market cap: 13241116406.41 (Large Cap ($10B-$200B))
P/E ratio: 9.764561469818693
Debt to equity: 0.5320201589952354
Free cash flow (dilution adjusted): 11564676.16938832
Operating income: 17457445.336285636
Net income: 9383047.3290894
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 4478.T (annual, report date 2025-06-30)
Altman Z-score: 4.938957442088045 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 4.175454187844423%
Earnings yield: 0.0034408974403048395%
Return on net tangible assets: 11.294704708683723%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.8704558640390547%
Free cash flow margin: -3.8853731557178666%
Revenue growth: 45.46625994270848%
Rule of 40 score: 41.58088678699062
Market cap: 227906872805 (Mega Cap (>= $200B))
P/E ratio: 166.35246740568047
Debt to equity: 0.4882196414728549
Free cash flow (dilution adjusted): -8944692.776086355
Operating income: 4227601.716025463
Net income: 9479822.861887628
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 5724.T (annual, report date 2025-09-30)
Altman Z-score: 2.0064578567633005 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.767599542684003%
Earnings yield: 0.023059934821299328%
Return on net tangible assets: -18.408911799045512%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.598018504603019%
Free cash flow margin: -13.27910960974047%
Revenue growth: 4.743524703757487%
Rule of 40 score: -8.535584905982983
Market cap: 6391682840.070001 (Mid Cap ($2B-$10B))
P/E ratio: 21.288578604016788
Debt to equity: 1.119580489854834
Free cash flow (dilution adjusted): -7761924.62987887
Operating income: 3317254.374158816
Net income: 2020457.604306864
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 7033.T (annual, report date 2025-12-31)
Altman Z-score: 10.154813948553965 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 55.46470354602585%
Earnings yield: 0.09263350551509296%
Return on net tangible assets: 40.4685862438323%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 44.002862201215635%
Free cash flow margin: 9.000362251990046%
Revenue growth: 29.87929077579819%
Rule of 40 score: 38.87965302778824
Market cap: 21754494171.314404 (Large Cap ($10B-$200B))
P/E ratio: 11.967550801420627
Debt to equity: 0.05345991560483723
Free cash flow (dilution adjusted): 13273428.808899688
Operating income: 17535215.139696952
Net income: 11621955.11795921
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 7272.T (annual, report date 2025-12-31)
Altman Z-score: 2.0850294242780203 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 10.887481451314676%
Earnings yield: 0.036701106389798246%
Return on net tangible assets: 9.158060543241222%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.549187187374344%
Free cash flow margin: 0.9998804357819795%
Revenue growth: -1.2646117113286266%
Rule of 40 score: -0.2647312755466471
Market cap: 1105652569508.6077 (Mega Cap (>= $200B))
P/E ratio: 31.646132277423085
Debt to equity: 0.8714848880855459
Free cash flow (dilution adjusted): 162003708.20280033
Operating income: 743513841.8259702
Net income: 223374464.54830253
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ALGN (annual, report date 2025-12-31)
Altman Z-score: 4.716169410622209 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 30.227978610995486%
Earnings yield: 5.312551539767172%
Return on net tangible assets: 15.74594305391177%
Capitalized R&D asset: 728380240
ROCI (R&D adjusted): 11.798905096873034%
Rosenberg metric: -0.24202503006573275
Free cash flow margin: 7.556647345552525%
Revenue growth: 0.8990220584484367%
Rule of 40 score: 8.455669404000961
Market cap: 11183170531.050001 (Large Cap ($10B-$200B))
P/E ratio: 27.252694720007995
Debt to equity: 0.028264224539143675
Free cash flow (dilution adjusted): 304908000
Operating income: 585311000
Net income: 410351000
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BZUN (annual, report date 2025-12-31)
Altman Z-score: 1.4507719142136448 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.6406393480696821%
Earnings yield: 1.0429786628546756%
Return on net tangible assets: -2.804394613945834%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.2396724287589447%
Free cash flow margin: 2.4801108201582567%
Revenue growth: 10.077116420268334%
Rule of 40 score: 12.557227240426592
Market cap: 1000031955.5799999 (Small Cap ($300M-$2B))
Debt to equity: 0.4137696318298955
Free cash flow (dilution adjusted): 35237000
Operating income: 10707142.857142856
Net income: -28511428.57142857
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CLBT (annual, report date 2025-12-31)
Altman Z-score: 19.75359317002341 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 27.166850557803112%
Earnings yield: 0.6749620117149561%
Return on net tangible assets: 27.169331780154614%
Capitalized R&D asset: 61568242.94541253
ROCI (R&D adjusted): 11.648312157474926%
Rosenberg metric: 1.230369756872849
Free cash flow margin: 24.26593787775267%
Revenue growth: 36.08551448186245%
Rule of 40 score: 60.35145235961512
Market cap: 14301731683.621801 (Large Cap ($10B-$200B))
P/E ratio: 182.5923918446212
Debt to equity: 0.046808088900268
Free cash flow (dilution adjusted): 36297798.74213836
Operating income: 20905660.37735849
Net income: 24630817.610062893
Long score: 13 | Short score: 1
Recommendation: Long
Stock screener scorecard for FPMB.DE (annual, report date 2025-12-31)
Altman Z-score: 2.641596301523201 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 13.404250932855053%
Earnings yield: 6.829114855053821%
Return on net tangible assets: 10.299453078464287%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.468359285111605%
Free cash flow margin: 3.8394752074088365%
Revenue growth: 1.8071105873109408%
Rule of 40 score: 5.646585794719777
Market cap: 74600900759 (Large Cap ($10B-$200B))
P/E ratio: 17.967461647157997
Debt to equity: 0.3410258077098095
Free cash flow (dilution adjusted): 995000000
Operating income: 6502000000
Net income: 4152000000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for IRWD (annual, report date 2025-12-31)
Altman Z-score: -3.568270295905247 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 265.6325489845218%
Earnings yield: 12.02500077440199%
Return on net tangible assets: -9.801610611084794%
Capitalized R&D asset: 208096120
ROCI (R&D adjusted): 29.314715429781813%
Free cash flow margin: 37.06217436375363%
Revenue growth: -15.724936683645884%
Rule of 40 score: 21.33723768010774
Market cap: 554747178.22 (Small Cap ($300M-$2B))
P/E ratio: 23.098104601740435
Debt to equity: -2.2831248687150305
Free cash flow (dilution adjusted): 109760000
Operating income: 118759000
Net income: 24017000
Long score: 8 | Short score: 6
Recommendation: Long
Stock screener scorecard for LIF (annual, report date 2025-12-31)
Altman Z-score: 8.587649694242444 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.7020059765774342%
Earnings yield: 0.4982428249588901%
Return on net tangible assets: 43.35813219784378%
Capitalized R&D asset: 237485020
ROCI (R&D adjusted): 3.020736058492312%
Rosenberg metric: 0.8993022083469678
Free cash flow margin: 5.24269583497623%
Revenue growth: 31.76368295808164%
Rule of 40 score: 37.00637879305787
Market cap: 5197372660.74 (Mid Cap ($2B-$10B))
P/E ratio: 34.45802389903999
Debt to equity: 0.5662097624511567
Free cash flow (dilution adjusted): 25662000
Operating income: 18979000
Net income: 150832000
Long score: 9 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for MOS (annual, report date 2025-12-31)
Altman Z-score: 1.8787541133953387 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 6.976954769774076%
Earnings yield: 8.478692748169173%
Return on net tangible assets: 2.3998628134081845%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.262644348280018%
Free cash flow margin: -4.69035212903654%
Revenue growth: 8.35760779659798%
Rule of 40 score: 3.66725566756144
Market cap: 7517073130.599999 (Mid Cap ($2B-$10B))
P/E ratio: 13.064082604449078
Debt to equity: 0.4315361854473525
Free cash flow (dilution adjusted): -565300000
Operating income: 1078700000
Net income: 575400000
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for NPK (annual, report date 2025-12-31)
Altman Z-score: 7.403651574531238 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 11.256418926889111%
Earnings yield: 4.804571573011944%
Return on net tangible assets: 2.995394173093402%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.582633853979269%
Free cash flow margin: -7.183570197249783%
Revenue growth: 29.69801250811379%
Rule of 40 score: 22.51444231086401
Market cap: 759457237.14 (Small Cap ($300M-$2B))
P/E ratio: 22.95542368335147
Debt to equity: 0.08368026117655991
Free cash flow (dilution adjusted): -36171000
Operating income: 42942000
Net income: 33084000
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SABR (annual, report date 2025-12-31)
Altman Z-score: -0.2700258653556461 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 74.75019604867066%
Earnings yield: 6.86341345156736%
Return on net tangible assets: -14.721473432263213%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.985552021753005%
Free cash flow margin: -9.349425817480656%
Revenue growth: 0.9522577777615858%
Rule of 40 score: -8.39716803971907
Market cap: 537626051.2800001 (Small Cap ($300M-$2B))
P/E ratio: 1.0247972354689232
Debt to equity: -4.2894311704868135
Free cash flow (dilution adjusted): -259071000
Operating income: 295495000
Net income: 524617000
Long score: 6 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for USFD (annual, report date 2025-12-31)
Altman Z-score: 4.470229822007368 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 37.86109403810695%
Earnings yield: 4.6185674607781175%
Return on net tangible assets: -32.36331569664903%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.901081916537867%
Free cash flow margin: 2.2219967532467533%
Revenue growth: 4.084272777675106%
Rule of 40 score: 6.30626953092186
Market cap: 16587095129.919998 (Large Cap ($10B-$200B))
P/E ratio: 24.537122973254437
Debt to equity: 1.3287671232876712
Free cash flow (dilution adjusted): 876000000
Operating income: 1232000000
Net income: 676000000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for 2317.HK (annual, report date 2025-12-31)
Altman Z-score: 10.442765219978797 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.426005210638895%
Earnings yield: 0.27522977248260366%
Return on net tangible assets: 9.646465814238478%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.071331119520169%
Free cash flow margin: 4.894326733201686%
Revenue growth: -1.6853265530147636%
Rule of 40 score: 3.209000180186923
Market cap: 1065919424 (Small Cap ($300M-$2B))
P/E ratio: 0.8854612967723507
Debt to equity: 0.10039999999999999
Free cash flow (dilution adjusted): 2357455.01285347
Operating income: 2824678.6632390744
Net income: 2195501.2853470435
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 256A.T (annual, report date 2026-03-31)
Altman Z-score: 1.7630762373241073 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 13.852136957741957%
Earnings yield: 0.07898833897079127%
Return on net tangible assets: 10.02218303850748%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.998631139973893%
Free cash flow margin: 0.9715988653908297%
Revenue growth: -5.719567581091961%
Rule of 40 score: -4.747968715701131
Market cap: 39569526784 (Large Cap ($10B-$200B))
P/E ratio: 0.05141654357348379
Debt to equity: 0.6607
Free cash flow (dilution adjusted): 8464714.714714715
Operating income: 43230730.73073073
Net income: 30311561.561561562
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3951.T (annual, report date 2026-03-31)
Altman Z-score: 1.87984704340983 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.565078040963274%
Earnings yield: 0.03106618550156923%
Return on net tangible assets: 6.348106414389443%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.956543902128202%
Free cash flow margin: 0.7056135477801174%
Revenue growth: -4.9092322496577845%
Rule of 40 score: -4.203618701877667
Market cap: 18300882944 (Large Cap ($10B-$200B))
P/E ratio: 0.07217486758141456
Debt to equity: 0.5508
Free cash flow (dilution adjusted): 1970720.720720721
Operating income: 10160160.16016016
Net income: 10316566.566566566
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 5393.T (annual, report date 2026-03-31)
Altman Z-score: 8.270420741658546 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 17.46517816699381%
Earnings yield: 0.03919213141649047%
Return on net tangible assets: 13.179809257966967%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.516881782421295%
Free cash flow margin: 6.034321917835409%
Revenue growth: -8.073616115101496%
Rule of 40 score: -2.039294197266087
Market cap: 634367574016 (Mega Cap (>= $200B))
P/E ratio: 0.10904343749582562
Debt to equity: 0.046
Free cash flow (dilution adjusted): 95101351.35135135
Operating income: 231575325.3253253
Net income: 198686186.1861862
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 9324.T (annual, report date 2026-03-31)
Altman Z-score: 1.1543830509696777 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 3.537809723206779%
Earnings yield: 0.021508703656688867%
Return on net tangible assets: 6.238760686765993%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.025569750484919%
Free cash flow margin: 1.49203373945642%
Revenue growth: -0.2725408232777087%
Rule of 40 score: 1.2194929161787114
Market cap: 73097314304 (Large Cap ($10B-$200B))
P/E ratio: 0.06432545688299614
Debt to equity: 0.7254
Free cash flow (dilution adjusted): 7469969.96996997
Operating income: 26851851.85185185
Net income: 42304804.8048048
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ALPM.PA (annual, report date 2025-12-31)
Altman Z-score: 3.0800809780940304 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 18.1712815277955%
Earnings yield: 16.860529573082747%
Return on net tangible assets: 20.52239298199327%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.859354598022755%
Free cash flow margin: 7.143153048120113%
Revenue growth: 12.996011698460592%
Rule of 40 score: 20.139164746580704
Market cap: 132997688 (Micro Cap ($50M-$300M))
P/E ratio: 15.189800057954217
Debt to equity: 0.1773
Free cash flow (dilution adjusted): 14200000
Operating income: 20104705.88235294
Net income: 14298823.529411765
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ANCR.L (annual, report date 2025-12-31)
Altman Z-score: 4.0127986593934 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 35.944112702185635%
Earnings yield: 3.454100734598712%
Return on net tangible assets: -744.8731501057082%
Capitalized R&D asset: 2175084.1601094767
ROCI (R&D adjusted): 4.0903974896484305%
Free cash flow margin: 8.246265725476112%
Revenue growth: 29.778374591652607%
Rule of 40 score: 38.02464031712872
Market cap: 230268224 (Micro Cap ($50M-$300M))
P/E ratio: 0.45752895752895756
Debt to equity: 0.1328
Free cash flow (dilution adjusted): 9929729.729729729
Operating income: 8378378.378378378
Net income: 6862162.162162162
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for AYI (quarterly, report date 2026-05-31)
Altman Z-score: 5.332299354565278 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 15.185796213371042%
Earnings yield: 1.8933729700252149%
Return on net tangible assets: 50.30487804878049%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.024563957266513%
Free cash flow margin: 21.702838063439064%
Revenue growth: 13.47920810836412%
Rule of 40 score: 35.18204617180318
Market cap: 9882921984 (Mid Cap ($2B-$10B))
P/E ratio: 20.04664914586071
Debt to equity: 0.2821
Free cash flow (dilution adjusted): 260000000
Operating income: 193300000
Net income: 141000000
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BCE (quarterly, report date 2026-03-31)
Altman Z-score: 0.3260452865840652 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 4.231241496034248%
Earnings yield: 1.4114002653228106%
Return on net tangible assets: -15.72645023948909%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.8211684045136411%
Free cash flow margin: 4.993514915693904%
Revenue growth: -5.071021259194991%
Rule of 40 score: -0.07750634350108676
Market cap: 19862798336 (Large Cap ($10B-$200B))
P/E ratio: 5.180873180873181
Debt to equity: 1.8163
Free cash flow (dilution adjusted): 221582733.81294966
Operating income: 917266187.0503597
Net income: 479856115.10791373
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DATAPATTNS.NS (annual, report date 2026-03-31)
Altman Z-score: 82.26787360572771 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 23.05466697875218%
Earnings yield: 0.014883445746066341%
Return on net tangible assets: 15.577751591443304%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.823007860105772%
Free cash flow margin: 0.8748121154449215%
Revenue growth: 18.3496963625293%
Rule of 40 score: 19.224508477974222
Market cap: 256658505728 (Mega Cap (>= $200B))
P/E ratio: 0.6589442130226637
Debt to equity: 0.003
Free cash flow (dilution adjusted): 857354.811360746
Operating income: 37578423.06061891
Net income: 28759008.05426028
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for DATAPATTNS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 81.68052120423903 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 12.155080492054823%
Earnings yield: 0.007846978714084159%
Return on net tangible assets: 8.995005891925258%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.451257281499123%
Revenue growth: 89.49650057012047%
Rule of 40 score: 89.49650057012047
Market cap: 256658505728 (Mega Cap (>= $200B))
P/E ratio: 0.6589442130226637
Debt to equity: 0.003
Operating income: 19812420.51716829
Net income: 14665112.335735481
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DMP.AX (annual, report date 2025-06-30)
Altman Z-score: 1.704438300177702 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 34.07842268196817%
Earnings yield: 5.992216454614818%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.813494066530083%
Free cash flow margin: 3.979096843628612%
Revenue growth: -4.9859250909453285%
Rule of 40 score: -1.0068282473167165
Market cap: 1572797952 (Small Cap ($300M-$2B))
P/E ratio: 19.138071895424837
Debt to equity: 1.8099
Free cash flow (dilution adjusted): 59735294.11764706
Operating income: 163827450.98039216
Net income: -2420915.0326797385
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DSY.PA (quarterly, report date 2026-03-31)
Altman Z-score: 2.7050856289072414 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.942859348066582%
Earnings yield: 1.8472526640618252%
Return on net tangible assets: 17.413710969641848%
Capitalized R&D asset: 733958309.668695
ROCI (R&D adjusted): 2.9058048756759725%
Rosenberg metric: -0.6076756230357216
Free cash flow margin: 61.29737609329447%
Revenue growth: -12.284012663507632%
Rule of 40 score: 49.013363429786835
Market cap: 23960752128 (Large Cap ($10B-$200B))
P/E ratio: 21.289355322338828
Debt to equity: 0.2686
Free cash flow (dilution adjusted): 1063333333.3333334
Operating income: 399540229.88505745
Net income: 336206896.55172414
Long score: 9 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for DY6.DE (quarterly, report date 2026-03-31)
Altman Z-score: 2.1940904498166067 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.2028683784408976%
Earnings yield: 0.986516450990494%
Return on net tangible assets: 5.696763202725724%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.121938940630731%
Free cash flow margin: 15.865510900971893%
Revenue growth: -7.61950982771172%
Rule of 40 score: 8.246001073260173
Market cap: 45836242944 (Large Cap ($10B-$200B))
P/E ratio: 16.211988942237742
Debt to equity: 0.5636
Free cash flow (dilution adjusted): 604000000
Operating income: 312000000
Net income: 120000000
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for HRS.DE (quarterly, report date 2026-03-31)
Altman Z-score: 1.710008824379408 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 21.755337173839376%
Earnings yield: 0.9797563837229138%
Return on net tangible assets: -11.834586466165414%
Capitalized R&D asset: 295060000
ROCI (R&D adjusted): 1.9410982504113494%
Rosenberg metric: -0.2838709677419355
Free cash flow margin: -4.822423398328691%
Revenue growth: 1.69971671388102%
Rule of 40 score: -3.1227066844476705
Market cap: 49256382464 (Large Cap ($10B-$200B))
P/E ratio: 42.338348748987684
Debt to equity: 0.3457
Free cash flow (dilution adjusted): -277000000
Operating income: 642000000
Net income: 512000000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for INRN.SW (annual, report date 2025-12-31)
Altman Z-score: 9.424822227625267 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 14.473362028318594%
Earnings yield: 10.27508561614741%
Return on net tangible assets: 14.82106514929272%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.849767531026522%
Free cash flow margin: 7.6426072191956935%
Revenue growth: 11.12557858731339%
Rule of 40 score: 18.768185806509084
Market cap: 1086897920 (Small Cap ($300M-$2B))
P/E ratio: 40.50274908520845
Debt to equity: 0.0208
Free cash flow (dilution adjusted): 49740506.32911392
Operating income: 90534177.21518987
Net income: 70818987.34177215
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for LBRT (quarterly, report date 2026-06-30)
Altman Z-score: 1.524282865566062 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0.7886108204577214%
Earnings yield: 0.6929007012859333%
Return on net tangible assets: -3.3878479687374288%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7287488572329115%
Free cash flow margin: -8.480089113542364%
Revenue growth: 16.39391138129857%
Rule of 40 score: 7.9138222677562045
Market cap: 2833003264 (Mid Cap ($2B-$10B))
P/E ratio: 35.391891891891895
Debt to equity: 0.8214
Free cash flow (dilution adjusted): -100794000
Operating income: 26959000
Net income: 43121000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for OMV.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.8591597494609579 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.899197918924777%
Earnings yield: 3.805282040485341%
Return on net tangible assets: 6.991097922848666%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.6175584896919157%
Free cash flow margin: -2.613151152860803%
Revenue growth: -5.369689018187342%
Rule of 40 score: -7.982840171048144
Market cap: 20766267392 (Large Cap ($10B-$200B))
P/E ratio: 18.80408110551466
Debt to equity: 0.3696
Free cash flow (dilution adjusted): -175862068.96551725
Operating income: 1039080459.7701149
Net income: 1890804597.7011495
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ORLA (quarterly, report date 2026-03-31)
Altman Z-score: 2.756625740887644 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 12.524146624345772%
Earnings yield: 4.476358371434912%
Return on net tangible assets: 13.736799801170765%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.47462212284284%
Free cash flow margin: 15.435494087837837%
Revenue growth: -1.3375511680242924%
Rule of 40 score: 14.097942919813544
Market cap: 3475396096 (Mid Cap ($2B-$10B))
P/E ratio: 22.375
Debt to equity: 0.42469999999999997
Free cash flow (dilution adjusted): 42073381.29496403
Operating income: 138669784.17266187
Net income: 54248201.43884893
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for PAHC (quarterly, report date 2026-03-31)
Altman Z-score: 1.9660338084255073 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 4.374717107570643%
Earnings yield: 2.135320911250621%
Return on net tangible assets: 7.828220223272267%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.8386483363822674%
Free cash flow margin: 0.1248882133163687%
Revenue growth: 2.576288411649862%
Rule of 40 score: 2.701176624966231
Market cap: 1380620160 (Small Cap ($300M-$2B))
P/E ratio: 23.63948497854077
Debt to equity: 2.1797
Free cash flow (dilution adjusted): 479000
Operating income: 44653000
Net income: 24024000
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for RMDRIP.NS (annual, report date 2026-03-31)
Altman Z-score: 7.19749479383699 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 33.39163466925378%
Earnings yield: 0.10212369834041889%
Return on net tangible assets: 27.309051610303857%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 32.37081050219994%
Free cash flow margin: -10.816561751928363%
Revenue growth: 36.63279123839912%
Rule of 40 score: 25.81622948647076
Market cap: 7755219968 (Mid Cap ($2B-$10B))
P/E ratio: 0.29426296584130646
Debt to equity: 0.4765
Free cash flow (dilution adjusted): -2262611.275964392
Operating income: 5179525.222551929
Net income: 3702797.795676134
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for RMDRIP.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.964117583130656 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 8.088627140182828%
Earnings yield: 0.024737947879285897%
Return on net tangible assets: 9.893109101905539%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.841347660014425%
Revenue growth: -22.138796118785574%
Rule of 40 score: -22.138796118785574
Market cap: 7755219968 (Mid Cap ($2B-$10B))
P/E ratio: 0.29426296584130646
Debt to equity: 0.4765
Operating income: 1254662.9927935565
Net income: 1060311.5727002968
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SN (quarterly, report date 2026-03-31)
Altman Z-score: 6.9197736747274785 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 7.250860605868294%
Earnings yield: 0.7695628417181763%
Return on net tangible assets: 8.518728870858688%
Capitalized R&D asset: 195333030
ROCI (R&D adjusted): 4.3414228312495275%
Rosenberg metric: -3.182775996335318
Free cash flow margin: -15.921718905497286%
Revenue growth: -32.76943268263481%
Rule of 40 score: -48.691151588132094
Market cap: 21029928960 (Large Cap ($10B-$200B))
P/E ratio: 21.350806451612904
Debt to equity: 0.3116
Free cash flow (dilution adjusted): -224943000
Operating income: 164525000
Net income: 121462000
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SSRM (quarterly, report date 2026-03-31)
Altman Z-score: 3.166337327960386 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.275314419294646%
Earnings yield: 5.296205098718742%
Return on net tangible assets: -4.546866634499078%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.806874435271862%
Free cash flow margin: 26.673404632007397%
Revenue growth: 9.766120268067379%
Rule of 40 score: 36.43952490007477
Market cap: 5573210112 (Mid Cap ($2B-$10B))
P/E ratio: 11.264367816091953
Debt to equity: 0.0155
Free cash flow (dilution adjusted): 155180000
Operating income: 305329000
Net income: -106450000
Long score: 9 | Short score: 3
Recommendation: Long
Stock screener scorecard for TARIL.NS (annual, report date 2026-03-31)
Altman Z-score: 6.756193961034639 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 29.163089420155856%
Earnings yield: 0.04138968424072765%
Return on net tangible assets: 12.889328909343895%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 21.614395320664215%
Free cash flow margin: -8.973612882653063%
Revenue growth: 12.623016002291038%
Rule of 40 score: 3.6494031196379755
Market cap: 93531676672 (Large Cap ($10B-$200B))
P/E ratio: 0.3131368768256058
Debt to equity: 0.29600000000000004
Free cash flow (dilution adjusted): -23858626.53666808
Operating income: 37438533.27681221
Net income: 28843789.741415855
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for UNICHEMLAB.NS (annual, report date 2026-03-31)
Altman Z-score: 4.294657840187679 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.416733513026487%
Earnings yield: 0.01686803807039156%
Return on net tangible assets: 8.061848362229377%
Capitalized R&D asset: 2444680.4431111696
ROCI (R&D adjusted): 1.6448182743140163%
Rosenberg metric: -8.64907973394764
Free cash flow margin: -5.566798338435035%
Revenue growth: -5.178735634364689%
Rule of 40 score: -10.745533972799723
Market cap: 37832527872 (Large Cap ($10B-$200B))
P/E ratio: 0.0863631052811723
Debt to equity: 0.1841
Free cash flow (dilution adjusted): -12739508.266214497
Operating income: 6736964.815599831
Net income: 26795252.22551929
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UNICHEMLAB.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.8297032188425875 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0.6489482628183438%
Earnings yield: 0.004529454300166492%
Return on net tangible assets: 1.532917860412913%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5986322987901105%
Revenue growth: 4.983816087393859%
Rule of 40 score: 4.983816087393859
Market cap: 37832527872 (Large Cap ($10B-$200B))
P/E ratio: 0.0863631052811723
Debt to equity: 0.1841
Operating income: 1809029.2496820686
Net income: 1156210.258584146
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 4235.T (annual, report date 2025-12-31)
Altman Z-score: 1.4483969372821912 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 17.779971481847102%
Earnings yield: 0.05770798378501109%
Return on net tangible assets: 315.9029649595688%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.918434407974003%
Free cash flow margin: 7.434437794969105%
Revenue growth: 1.6417751879938616%
Rule of 40 score: 9.076212982962966
Market cap: 11514044991.676752 (Large Cap ($10B-$200B))
P/E ratio: 14.648912203151083
Debt to equity: 0.9106554583664659
Free cash flow (dilution adjusted): 9769196.342944825
Operating income: 10363787.481618822
Net income: 5025254.139760885
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4433.T (annual, report date 2025-08-31)
Altman Z-score: 3.2267591943512937 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.882833462524594%
Earnings yield: 0.12115936189588579%
Return on net tangible assets: 3.5881435257410312%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.264345631356246%
Free cash flow margin: 1.608591735329266%
Revenue growth: 7.2178505034584655%
Rule of 40 score: 8.826442238787731
Market cap: 19466772096 (Large Cap ($10B-$200B))
P/E ratio: 18.38222105382436
Debt to equity: 0.43395927003438245
Free cash flow (dilution adjusted): 6969139.587165339
Operating income: 17003883.0983037
Net income: 7214387.901083181
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for AYI (annual, report date 2025-08-31)
Altman Z-score: 5.673874274244051 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 47.62898178608682%
Earnings yield: 5.814310372514058%
Return on net tangible assets: 353.75766871165644%
Capitalized R&D asset: 240784000
ROCI (R&D adjusted): 14.953553866527363%
Rosenberg metric: 2.9012707722385143
Free cash flow margin: 11.227448453608249%
Revenue growth: 13.137203853163237%
Rule of 40 score: 24.364652306771486
Market cap: 9755396056.36 (Mid Cap ($2B-$10B))
P/E ratio: 24.597569481492688
Debt to equity: 0.36860068259385664
Free cash flow (dilution adjusted): 487900000
Operating income: 593600000
Net income: 396600000
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BCE (annual, report date 2025-12-31)
Altman Z-score: 0.6962237512519354 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 19.293749110066923%
Earnings yield: 6.087423683348499%
Return on net tangible assets: -108.11282740094023%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.052414981651786%
Free cash flow margin: 13.446133725682524%
Revenue growth: 4.631862185570515%
Rule of 40 score: 18.07799591125304
Market cap: 29664951774.9138 (Large Cap ($10B-$200B))
P/E ratio: 4.554030054484771
Debt to equity: 1.7614328614328618
Free cash flow (dilution adjusted): 2401459854.0145984
Operating income: 3956204379.5620437
Net income: 4754744525.547445
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CNQ.TO (annual, report date 2025-12-31)
Altman Z-score: 2.4723029026569776 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 9.923037950252118%
Earnings yield: 3.862933555745226%
Return on net tangible assets: 41.27485011044493%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.820096219274893%
Free cash flow margin: 18.418728915253467%
Revenue growth: 11.063434840355606%
Rule of 40 score: 29.482163755609072
Market cap: 95087518900.00002 (Large Cap ($10B-$200B))
P/E ratio: 8.788125591497229
Debt to equity: 0.37454356939999095
Free cash flow (dilution adjusted): 5937956204.379561
Operating income: 6004379562.043796
Net income: 7897810218.978102
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for DLHC (annual, report date 2025-09-30)
Altman Z-score: 1.7057062824677292 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 169.48707592891762%
Earnings yield: 7.657268787158691%
Return on net tangible assets: -15.631940410701473%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.768766734410788%
Free cash flow margin: 6.244176291810959%
Revenue growth: -12.991965893563876%
Rule of 40 score: -6.747789601752917
Market cap: 81885647.75 (Micro Cap ($50M-$300M))
P/E ratio: 60.12162096182086
Debt to equity: 1.2834239274774695
Free cash flow (dilution adjusted): 21511000
Operating income: 16786000
Net income: 1362000
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for DSY.PA (annual, report date 2025-12-31)
Altman Z-score: 3.88486512532298 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 39.83433304770065%
Earnings yield: 7.5857149929315%
Return on net tangible assets: 82.55535918494647%
Capitalized R&D asset: 2904860612.745098
ROCI (R&D adjusted): 11.357839148133166%
Rosenberg metric: 0.5438281485817775
Free cash flow margin: 20.75949773080809%
Revenue growth: 13.342875968463863%
Rule of 40 score: 34.10237369927195
Market cap: 30905230137.6 (Large Cap ($10B-$200B))
P/E ratio: 25.840493426086958
Debt to equity: 0.360218231416231
Free cash flow (dilution adjusted): 1522941176.4705882
Operating income: 1640705882.3529413
Net income: 1407058823.5294118
Long score: 14 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for DY6.DE (annual, report date 2025-12-31)
Altman Z-score: 2.938635143642909 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.040174740619394%
Earnings yield: 12.192331522497902%
Return on net tangible assets: 40.967851099830796%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.01519281794061%
Free cash flow margin: 15.696997905515476%
Revenue growth: 7.8293601003764115%
Rule of 40 score: 23.526358005891886
Market cap: 41332539575.55294 (Large Cap ($10B-$200B))
P/E ratio: 15.416836842802292
Debt to equity: 0.5529366306027821
Free cash flow (dilution adjusted): 2698000000
Operating income: 3856000000
Net income: 2681000000
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for HRS.DE (annual, report date 2025-12-31)
Altman Z-score: 2.41568273472517 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 53.323412698412696%
Earnings yield: 3.2811156152714407%
Return on net tangible assets: -34.95061011040093%
Capitalized R&D asset: 1039450000
ROCI (R&D adjusted): 6.214690072444414%
Rosenberg metric: 0.19611650485436893
Free cash flow margin: 10.592270752343929%
Revenue growth: 2.5322391559202813%
Rule of 40 score: 13.12450990826421
Market cap: 54967969071.52941 (Large Cap ($10B-$200B))
P/E ratio: 34.22663080419017
Debt to equity: 0.5661319073083779
Free cash flow (dilution adjusted): 2316000000
Operating income: 2150000000
Net income: 1606000000
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for LBRT (annual, report date 2025-12-31)
Altman Z-score: 2.914989151605715 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 3.4452176077615992%
Earnings yield: 2.3193243956875746%
Return on net tangible assets: 2.5355370103935324%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.179722560494328%
Free cash flow margin: -0.6943633184860348%
Revenue growth: -7.161841701850753%
Rule of 40 score: -7.856205020336788
Market cap: 2994562483.6000004 (Mid Cap ($2B-$10B))
P/E ratio: 20.251044711642503
Debt to equity: 0.2974117425220875
Free cash flow (dilution adjusted): -27817000
Operating income: 90239000
Net income: 147872000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for OMV.DE (annual, report date 2025-12-31)
Altman Z-score: 1.4222099079683503 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.275479033601776%
Earnings yield: 15.40693527042524%
Return on net tangible assets: 1.1529048048434898%
Capitalized R&D asset: 181127696.07843137
ROCI (R&D adjusted): 10.111000458563936%
Rosenberg metric: 3.747963800904975
Free cash flow margin: 5.619549119631397%
Revenue growth: 4.809273789686897%
Rule of 40 score: 10.428822909318296
Market cap: 14376646613.7 (Large Cap ($10B-$200B))
P/E ratio: 9.458320140592106
Debt to equity: 0.3543826996366215
Free cash flow (dilution adjusted): 1607058823.5294118
Operating income: 4207058823.529412
Net income: 1788235294.1176472
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ORLA (annual, report date 2025-12-31)
Altman Z-score: 4.243168020911291 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 29.778570253490035%
Earnings yield: 10.833380977705822%
Return on net tangible assets: 33.30772958787114%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 29.691532148696925%
Free cash flow margin: 63.93082019622245%
Revenue growth: 221.06826474465583%
Rule of 40 score: 284.9990849408783
Market cap: 6915700185.183501 (Mid Cap ($2B-$10B))
P/E ratio: 64.69619893524954
Debt to equity: 0.5581845115628342
Free cash flow (dilution adjusted): 493658394.1605839
Operating income: 335599270.0729927
Net income: 78025547.44525547
Long score: 11 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PAHC (annual, report date 2025-06-30)
Altman Z-score: 2.2533683169575442 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.09697731618267%
Earnings yield: 5.282472050283292%
Return on net tangible assets: 29.31718433490885%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.348717055124144%
Free cash flow margin: 3.1718503489004526%
Revenue growth: 27.369730533891335%
Rule of 40 score: 30.541580882791788
Market cap: 531352160.03999996 (Small Cap ($300M-$2B))
P/E ratio: 11.00928559671805
Debt to equity: 2.6657332278547474
Free cash flow (dilution adjusted): 41114000
Operating income: 110465000
Net income: 48264000
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for SN (annual, report date 2025-12-31)
Altman Z-score: 6.152020851312898 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 41.59719720497947%
Earnings yield: 4.304598459439265%
Return on net tangible assets: 49.98392425193826%
Capitalized R&D asset: 679034340
ROCI (R&D adjusted): 22.768610868265558%
Rosenberg metric: 1.3903143670027456
Free cash flow margin: 6.727119128239395%
Revenue growth: 15.74617188787331%
Rule of 40 score: 22.473291016112704
Market cap: 15836130410.1 (Large Cap ($10B-$200B))
P/E ratio: 22.57872463207932
Debt to equity: 0.33686544147677444
Free cash flow (dilution adjusted): 430481000
Operating income: 920281000
Net income: 701374000
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SSRM (annual, report date 2025-12-31)
Altman Z-score: 2.3037225997008663 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 9.74247341728022%
Earnings yield: 8.143585974986562%
Return on net tangible assets: 8.031534537725218%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.574166461359708%
Free cash flow margin: 12.093981665855647%
Revenue growth: 63.68094992256066%
Rule of 40 score: 75.77493158841631
Market cap: 4548204276.320001 (Mid Cap ($2B-$10B))
P/E ratio: 11.492503616691177
Debt to equity: 0.08757504773710588
Free cash flow (dilution adjusted): 197088000
Operating income: 469482000
Net income: 395754000
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for TEX (annual, report date 2025-12-31)
Altman Z-score: 2.826479546388918 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 20.670147954743253%
Earnings yield: 4.597551831177134%
Return on net tangible assets: -1634.7826086956522%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.592084006462036%
Free cash flow margin: 5.349566500645637%
Revenue growth: 5.734347571679345%
Rule of 40 score: 11.083914072324983
Market cap: 6063758019.84 (Mid Cap ($2B-$10B))
P/E ratio: 27.437819094298643
Debt to equity: 1.2334128878281623
Free cash flow (dilution adjusted): 290000000
Operating income: 475000000
Net income: 221000000
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for C (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.932295443838038%
Capitalized R&D asset: 0
Free cash flow margin: -87.0195862133712%
Revenue growth: 5.628966679888933%
Rule of 40 score: -81.39061953348227
Market cap: 193806796000 (Large Cap ($10B-$200B))
P/E ratio: 13.410378909493495
Debt to equity: 1.7196780499667947
Free cash flow (dilution adjusted): -74152000000
Net income: 14452000000
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CREX (annual, report date 2025-12-31)
Altman Z-score: -0.13781417672425267 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 519420
ROCI (R&D adjusted): -3.2761456520447143%
Free cash flow margin: -21.88810455689125%
Revenue growth: 12.541786290163998%
Rule of 40 score: -9.346318266727252
Market cap: 34185498.12 (Nano Cap (< $50M))
Debt to equity: 1.3797625340544057
Free cash flow (dilution adjusted): -12527000
Operating income: -3154000
Net income: -8276000
Long score: 0 | Short score: 13
Recommendation: Short